Bruno Domon is an expert in biological mass spectrometry and proteomics heading at the Luxembourg Clinical Proteomics Center, CRP-Santé, Strassen, Luxembourg since 2010 He joined the Centre de Recherche Public Santé in Luxembourg to lead the new Clinical Proteomics Center, funded by the Fonds National de la Recherche through a PEARL grant. His main focus is the development of novel mass spectrometry-based proteomics methodologies, and its application to biomarker discovery and evaluation, and to proteomics in general. His current interest is in personalized medicine and personalized therapies and he is collaborating with the clinicians to develop new diagnostics tools in the field of lung cancer.